Problems.
- pushed by Giuliani and Trump not the Fda
- not proved safety
- umbilical killer cells might trigger immune response, exact opposite to quelling the storm. So might end up killing patients
- no compassionate use granted
- initial trial 60 days will then need placebo trial after - another 3- 4 months. 6 months, then will need to apply to fda
- meso milder dose is proving more effective than other treatments
Conclusion - shot in the dark.
- Forums
- ASX - By Stock
- MSB
- Ann: US NIH Trials Network to Conduct COVID-19 Phase 2/3 Trial
Ann: US NIH Trials Network to Conduct COVID-19 Phase 2/3 Trial, page-210
-
- There are more pages in this discussion • 67 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.46 |
Change
-0.030(2.01%) |
Mkt cap ! $1.689B |
Open | High | Low | Value | Volume |
$1.57 | $1.58 | $1.46 | $7.070M | 4.642M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 45190 | $1.46 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.47 | 9321 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
15 | 85602 | 1.450 |
9 | 35600 | 1.445 |
9 | 52673 | 1.440 |
7 | 138590 | 1.435 |
5 | 67329 | 1.430 |
Price($) | Vol. | No. |
---|---|---|
1.460 | 15993 | 7 |
1.465 | 35775 | 8 |
1.470 | 20074 | 7 |
1.475 | 27979 | 4 |
1.480 | 27865 | 4 |
Last trade - 11.00am 07/10/2024 (20 minute delay) ? |
Featured News
NEWS
Antler Copper Project hits major permitting milestone – air quality permit advances to final review
MSB (ASX) Chart |